Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
CTX- 0294885 represents a powerful new reagent for analysis of kinome signaling networks that may facilitate development of targeted therapeutic strategies
Tubacin and bortezomib induce synergistic antitumor activity in MM cell lines
Lactacystin also inhibits the lysosomal enzyme cathepsin A
InChiKey: BKGUPIVDQHHVMV-NTEUORMPSA-N
1038/s41374-019-0276-z
galacto-Dapagliflozin Size:Contact [email protected] for quotation CTX- 0294885 represents a powerfulKi = 2 nM galacto Dapagliflozin is a potent inhibitor of human SGLT2. Renal glucose transport is mediated by sodium glucose cotransporters (SGLT) 1 and 2. In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney. In vitro: It was found that galacto dapagliflozin was a selective inhibitor of hSGLT2, but was less potent than dapagliflozin for both transporters. Both phlorizin and galacto dapagliflozin rapidly dissociated